Advertisement

Topics

Boulder's Clovis pairs with Bristol-Myers on breast, ovarian, prostate cancer treatments

06:14 EDT 2 Aug 2017 | Topix

Bouler-based Clovis Oncology has partnered with Bristol-Myers Squibb to evaluate the combination of two of the companies' drugs on several types of tumors. Three mid- to late-stage studies will evaluate the efficacy of Bristol-Myers' Opdivo in tandem with Clovis' Rubraca.

Original Article: Boulder's Clovis pairs with Bristol-Myers on breast, ovarian, prostate cancer treatments

NEXT ARTICLE

More From BioPortfolio on "Boulder's Clovis pairs with Bristol-Myers on breast, ovarian, prostate cancer treatments"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...